CALECIM’s parent company CellResearchCorp obtains stem cells from the umbilical cord lining membrane of red deer for the production of CALECIM’s active ingredient. This source, in both humans and other mammals, is the most abundant source of epithelial and mesenchymal stem cells known to date. The numbers that can be harvested vastly exceeds any other source, including bone marrow and fat.
The stem cells isolated from cord lining membrane are neonatal (very young) and as such as more potent and robust compared to their adult sourced counterparts.
The red deer from which the stem cells are sourced are organically and ethically raised in New Zealand. CellResearchCorp chose red deer as its source of umbilical cord lining for CALECIM Professional as there are no known diseases that are transmitted from deer to humans.
Extraction of these stem cells causes no harm or distress to these deer.